Calvin N Ho

8PUBLICATIONS
18CO-AUTHORS
Epidemiological methodsAllergyPharmacogenomicsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2026
Efficacy of benralizumab in reducing cough and/or dyspnea frequency, and improving cough-specific health-related quality of life in patients with severe eosinophilic asthma in Asia.

|Aug 25, 2026
Benralizumab in bronchiectasis: results from the phase 3 MAHALE study.

|Mar 31, 2026
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Princess U Ogbogu, Florence Roufosse, Praveen Akuthota

|Mar 25, 2026
Multi-stakeholder use of patient experience data (PED): current state and future opportunities for the application of PED to inform decision-making.

Chisom Kanu, Jessica L Abel, Sarah L Knight

|Jan 08, 2025
Patient experience with eosinophilic esophagitis symptoms and impacts on daily life based on in-trial qualitative interviews.

Calvin N Ho, Harald Fjällbrant, Evan S Dellon

|Dec 18, 2024
Assessing usability of electronic patient-reported outcome measures in older people with and without a rare dermatologic disorder.

Calvin N Ho, Anna Kündig, Lila Bahadori

Pageof 2

Frequent Collaborators

2 joint publications

Amy D Klion

2 joint publications

Gerben Bouma

2 joint publications

Piotr Kuna

1 joint publications

Sofia Necander